Karpas Strategies, LLC Johnson & Johnson Transaction History

Karpas Strategies, LLC

$262 Million
Q2 2024

A detailed history of Karpas Strategies, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Karpas Strategies, LLC holds 130,223 shares of JNJ stock, worth $19 Million. This represents 7.27% of its overall portfolio holdings.

Number of Shares

130,223

Previous 130,949 0.55%

Holding current value

$19 Million

Previous $20.7 Million 8.12%

% of portfolio

7.27%

Previous 7.86%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	SELL	$144.38 - $157.78 $104,819 - $114,548	-726 Reduced 0.55%	130,223 $19 Million
Q1 2024 May 06, 2024	SELL	$155.22 - $162.74 $479,164 - $502,378	-3,087 Reduced 2.3%	130,949 $20.7 Million
Q4 2023 Feb 07, 2024	BUY	$145.6 - $158.88 $17,180 - $18,747	118 Added 0.09%	134,036 $21 Million
Q3 2023 Nov 09, 2023	SELL	$155.75 - $174.48 $6,697 - $7,502	-43 Reduced 0.03%	133,918 $20.9 Million
Q2 2023 Aug 10, 2023	SELL	$154.35 - $166.11 $17,750 - $19,102	-115 Reduced 0.09%	133,961 $22.2 Million
Q1 2023 May 02, 2023	SELL	$151.05 - $180.26 $5,588 - $6,669	-37 Reduced 0.03%	134,076 $20.8 Million
Q4 2022 Feb 07, 2023	BUY	$160.2 - $179.79 $15,539 - $17,439	97 Added 0.07%	134,113 $23.7 Million
Q3 2022 Oct 28, 2022	BUY	$161.33 - $179.52 $645 - $718	4 Added 0.0%	134,016 $21.9 Million
Q2 2022 Jul 19, 2022	BUY	$168.19 - $186.01 $15,978 - $17,670	95 Added 0.07%	134,012 $23.8 Million
Q1 2022 Apr 19, 2022	BUY	$158.14 - $179.59 $18,818 - $21,371	119 Added 0.09%	133,917 $23.7 Million
Q4 2021 Feb 07, 2022	BUY	$155.93 - $173.01 $706,051 - $783,389	4,528 Added 3.5%	133,798 $22.9 Million
Q3 2021 Nov 04, 2021	BUY	$161.5 - $179.47 $37,952 - $42,175	235 Added 0.18%	129,270 $21.4 Million
Q2 2021 Jul 28, 2021	BUY	$159.48 - $171.07 $74,158 - $79,547	465 Added 0.36%	129,035 $21.3 Million
Q1 2021 May 05, 2021	SELL	$153.07 - $170.48 $145,416 - $161,956	-950 Reduced 0.73%	128,570 $21.1 Million
Q1 2020 Apr 22, 2020	SELL	$111.14 - $153.99 $572,371 - $793,048	-5,150 Reduced 3.82%	129,520 $17 Million
Q3 2019 Oct 22, 2019	SELL	$126.95 - $142.14 $317,375 - $355,349	-2,500 Reduced 1.82%	134,670 $17.4 Million
Q1 2019 Apr 18, 2019	SELL	$125.72 - $139.79 $37,716 - $41,937	-300 Reduced 0.22%	137,170 $19.2 Million
Q1 2018 May 08, 2018	SELL	$125.1 - $148.14 $187,650 - $222,209	-1,500 Reduced 1.08%	137,470 $17.6 Million
Q3 2017 Nov 08, 2017	BUY	$129.47 - $135.38 $18 Million - $18.8 Million	138,970	138,970 $18.1 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Karpas Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Karpas Strategies, LLC with notifications on news.

Account

Karpas Strategies, LLC Johnson & Johnson Transaction History